Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INCREDIBLE incremental haemodialysis plus Ketosteril
2025-524093-41-00Phase 2Authorised
- Sponsor
- Centre Hospitalier Le Mans
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of Ketosteril in chronic kidney disease (CKD) (2 arms), sponsored by Centre Hospitalier Le Mans. Planned start May 2026; status: authorised.
02
Drugs
Ketosteril
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2025-524093-41-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-524093-41-00.